Grace Capital’s Teladoc Health TDOC Stock Holding History

Grace Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,266	Closed	-$311K	–	224
2018 Q4	$311K	Sell	6,266 -5,700	-48%	-$349K	0.14%	143
2018 Q3	$1.03M	Buy	+11,966	New	+$853K	0.4%	64

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Grace Capital's TDOC Position: Q1 2019 in Review

Grace Capital sold out of Teladoc Health (TDOC) in Q1 2019, closing a stake of 6,266 shares — an estimated $311K sold.

Grace Capital first reported a position in TDOC in Q3 2018 and held it in 2 quarters. The position peaked at $1.03M in Q3 2018. 364 funds tracked by Wall St. Rank hold TDOC as of Q1 2019.

Grace Capital reported no remaining Teladoc Health position as of Q1 2019 after selling out during the quarter.
Grace Capital sold 6,266 Teladoc Health shares in Q1 2019, an estimated $311K.
Grace Capital first reported a position in Teladoc Health in Q3 2018 and held it in 2 quarters.
Grace Capital's Teladoc Health position peaked at $1.03M in Q3 2018.
364 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2019.

Based on Grace Capital's 13F filing for Q1 2019, filed 15 May 2019.